Free Trial
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel
NASDAQ:FBLG

FibroBiologics Q2 2024 Earnings Report

FibroBiologics logo
$1.16 -0.08 (-6.45%)
Closing price 04:00 PM Eastern
Extended Trading
$1.15 -0.01 (-0.86%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

FibroBiologics EPS Results

Actual EPS
-$1.80
Consensus EPS
-$1.80
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

FibroBiologics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

FibroBiologics Announcement Details

Quarter
Q2 2024
Date
8/7/2024
Time
N/A
Conference Call Date
Wednesday, August 7, 2024
Conference Call Time
7:30AM ET

Upcoming Earnings

FibroBiologics' Q2 2026 earnings is estimated for Wednesday, May 13, 2026, based on past reporting schedules

Conference Call Resources

Powered by Quartr

Earnings Documents

FibroBiologics' Q2 2024 Press ReleasePress Release
(8-K)
FibroBiologics' Q2 2024 Quarterly reportQuarterly report
(10-Q)

FibroBiologics Earnings Headlines

FibroBiologics CEO Issues Letter to Shareholders
May 5 at 8:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/05/3287694/0/en/fibrobiologics-ceo-issues-letter-to-shareholders.html
FibroBiologics (NASDAQ:FBLG) Receives Hold Rating from Maxim Group
May 5 at 3:36 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30759137
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
May 8 at 1:00 AM  |  InvestorPlace (Ad)
Maxim Group downgrades FibroBiologics (FBLG)
May 4, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/maxim-group-downgrades-fibrobiologics-fblg/ar-AA22nEic
FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring
May 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/04/3287105/0/en/fibrobiologics-reports-preclinical-data-showing-fibroblast-spheroids-may-actively-reprogram-the-burn-wound-environment-to-drive-healing-and-reduce-scarring.html
Exclusive: FibroBiologics targets 2026 data readout after trial progress for diabetic foot ulcer study
May 4, 2026  |  msn.comhttps://www.msn.com/en-us/technology/biotechnology/exclusive-fibrobiologics-targets-2026-data-readout-after-trial-progress-for-diabetic-foot-ulcer-study/ar-AA22lTOd
See More FibroBiologics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like FibroBiologics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on FibroBiologics and other key companies, straight to your email.

About FibroBiologics

FibroBiologics (NASDAQ:FBLG), Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. It holds 150+ U.S. and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics, Inc. was incorporated in 2021 and is based in Houston, Texas.

View FibroBiologics Profile
Earnings Tools